Functional gastrointestinal disorders (FGIDs) comprise a constellation of symptoms that have no identifi able structural or biochemical abnormality. In view of the lack of data from large-scale population-based studies evaluating the effects of these disorders on survival, we aimed to examine whether FGIDs are associated with impaired survival.
INTRODUCTION
Functional gastrointestinal disorders (FGIDs) are common in the community with a prevalence reported as high as 40 % ( 1 ). Although most patients do not seek medical evaluation for their symptoms, FGIDs have still been estimated to account for up to half of the patient care time for gastroenterologists ( 2 -5 ) . Seen by some physicians as predominantly forms of psychological disorders, FGIDs have historically carried potentially harmful stigmata
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METHODS
Th is is a population-based historical cohort study of randomly selected subjects from Olmsted County, MN. Th is research was approved by the Mayo Foundation Institutional Review Board.
Subjects
Th e Olmsted County population comprises ~ 120,000 persons of whom 89 % are Caucasian. Although the education level is slightly higher as well as the proportion employed in the health-related services industry, this community otherwise is sociodemographically similar to the US white population ( 22 ) . Approximately 80 % of the local population resides within 5 miles of Rochester, MN and virtually all residents receive their medical care almost exclusively from two group practices: Mayo Medical Center and Olmsted Medical Center. Th e Mayo Clinic has maintained a common medical records system with its two affi liated hospitals (St Marys and Rochester Methodist) for over 100 years. All diagnoses and surgical procedures are recorded and indexed, including all diagnoses made from outpatients seen in the offi ce or clinic consultations, emergency room visits, or nursing home care. Diagnoses are also recorded for hospital inpatients, at autopsy examination, or on death certifi cates. Th e Rochester Epidemiology Project further developed this system by creating similar indices for the records of other providers to local residents, most notably the Olmsted Medical Center (Olmsted Medical Group and its affi liated Olmsted Community Hospital). Th is medical records linkage system allows access to details of the medical care provided to Olmsted County residents for research as long as subjects provide research authorization. Annually, over 80 % of the entire population is attended by one or both of these two practices, and ~ 96 % of the population is seen at least once during a 4-year period ( 22 ) . Th us, this medical records linkage system by the Rochester Epidemiology Project provides essentially a true enumeration of this population from which random samples can be drawn.
Sampling, inclusion, and exclusion criteria
Using data resources of the Rochester Epidemiology Project, a series of age-and gender-stratifi ed random samples of Olmsted County residents were drawn between 1988 and 1993. Subjects in these samples were mailed validated gastrointestinal (GI) symptom questionnaires (discussed below) from November 1988 to June 1994 representing an initial, or baseline, survey. Th e cohort of subjects that returned questionnaires, which contained criteria for defi ning specifi c FGID, was identifi ed and consisted of subjects 20 years of age and greater at the time of mailing. Results based on these surveys have been reported earlier ( 23 -30 ) . Th e complete medical records of subjects listed in the samples were reviewed.
Subjects were excluded from the mailings if they had signifi cant illnesses that might cause GI symptoms; impair their ability to complete the questionnaire (e.g., metastatic cancer, major stroke) ( n = 91); had a history of major abdominal surgery ( n = 37); had a major psychotic episode, mental retardation, or dementia ( n = 46). Incarcerated individuals in the local Federal Medical Center ( n = 8), and subjects for whom contact was prohibited for legal reasons were also excluded ( n = 190). Residency confi rmation was also performed and excluded subjects no longer residing within the county ( n = 551) or deceased ( n = 17).
For these surveys, a study questionnaire and an explanatory letter were mailed to all eligible subjects. Reminder letters were typically mailed as needed at 2, 4, and 7 weeks. Th e remaining nonresponders were typically then contacted by telephone at 10 weeks to request their participation and verify their residency within the county. Subjects were assumed to no longer reside within the county if the questionnaire was not delivered and no new address FUNCTIONAL GI DISORDERS was known. Although subsets of these subjects received subsequent follow-up surveys between 1998 and 2004, these responses were not included in this study.
A total of 5,262 randomly selected subjects were sent questionnaires that included questions necessary to defi ne specifi c FGIDs that included dyspepsia, functional constipation, IBS, abdominal pain, and functional diarrhea. Of the 4,176 that responded, 243 were removed aft er declining research authorization (or were registered solely at a diff erent medical institution in Olmsted County, MN). Th is left 3,933 subjects for the analysis.
Questionnaire
Th e original Bowel Disease Questionnaire (BDQ) was designed as a self-report instrument to measure symptoms experienced over the prior year and to collect the past medical history ( 31 ) . Previous testing has shown the symptom assessment of the BDQ to have adequate reliability and validity with a median statistic (chance corrected measure of agreement) of 0.78 (range 0.52 -1.00) ( 31, 32 ) . Th e BDQ has also been assessed in the outpatient setting and was demonstrated to have adequate content and construct as well as discriminatory validity ( 31 ) . Th e original BDQ contained 46 GI symptom-related items; 25 items that measured past illness, health-care use, and sociodemographic data; and the Somatic Symptom Checklist, which was a valid measure of somatic complaints. Th e Somatic Symptom Checklist is a self-report scale that contains 17 somatic complaints and asks respondents to rate each item on frequency and occurrence; frequency indicated on a scale from 0 (indicating not a problem) to 4 (indicating daily), and intensity also scaled from 0 (indicated not a problem) to 4 (indicating extremely bothersome when symptom occurs) ( 33 ) . Th e Somatic Symptom Checklist was adapted to yield a composite score derived by summing the cross-product of each item ' s frequency by intensity. Derivatives of the original BDQ have also been created for specifi c conditions or populations, such as the Gastroesophageal Refl ux Questionnaire and the Elderly BDQ ( 34, 35 ) . Reliability testing was also performed on these derivatives before implementation ( 34, 35 ) . All subjects received either the BDQ or a validated derivative. Of the 3,933 eligible subjects, 1,599 responded to the BDQ, 852 responded to the Gastroesophageal Refl ux Questionnaire, and 1,482 responded to the Elderly BDQ.
Defi nition of symptom categories
For this study, subjects were classifi ed into a priori symptom groups based on their responses to each of the questionnaires. Attempts were made so that defi nitions for each symptom category were modifi cations based on Rome classifi cation ( 36 ) . Of note, subjects with IBS were excluded from inclusion in the other FGID categories including functional constipation, functional diarrhea, dyspepsia, and abdominal pain.
Irritable bowel syndrome . IBS was defi ned as a combination of frequent (more than six times per year) abdominal pain and alteration in bowel habit in the past year. Th e abdominal pain had to have two of the following characteristics consistent with Rome criteria: (i) relieved by defecation; (ii) associated with a change in stool frequency; or (iii) associated with a change in stool form ( 8 ) . Th e original BDQ did not ask the questions " do you oft en have less bowel movements with abdominal pain? " or " do you oft en have harder stools with abdominal pain? " but these were included in later versions. Notably, the defi nition applied has been tested and applied in previous investigations ( 1, 24, 26 ) .
Functional constipation . Subjects with symptoms of IBS (as defi ned above) were excluded. Functional constipation was defi ned as having two or more of the following symptoms, with each occurring more than 25 % of the time in the past year: (i) fewer than three bowel movements per week; (ii) straining during a bowel movement; (iii) passing hard or lumpy stools; and (4) feeling of incomplete evacuation aft er a bowel movement ( 24 ).
Functional diarrhea . Subjects with symptoms of IBS (as defi ned above) were excluded. Functional diarrhea was defi ned as having one or more of the following symptoms, with each occurring more than 25 % of the time in the past year: (i) reporting more than thre bowel movements a day; (ii) having loose or watery stools; and (iii) fecal urgency or urgency to have a bowel movement ( 24 ) .
Dyspepsia . Subjects with symptoms of IBS (as defi ned above) were excluded. Dyspepsia was defi ned as having two or more of the following: (i) frequent upper abdominal pain ( > 6 times per year); (ii) nausea (at least three or more episodes per week); (iii) vomiting ( ≥ 3 episodes per week); (iv) early satiety; and (v) loss of appetite ( 23, 24 ) . Th e original BDQ did not ask the questions " early satiety " or " loss of appetite " but these were included in later versions.
Abdominal pain . Subjects with symptoms of IBS (as defi ned above) were excluded. Abdominal pain was defi ned as having more than six episodes of abdominal pain in the prior year.
Follow-up and causes of death
Mayo Clinic maintains an institutional database (or " Registration " ) that periodically updates routine patient follow-up (e.g., correspondence with patients or next of kin or local providers of medical care), this includes clinic visits. Th is database is up-to-date for all Olmsted County residents. From this database, vital status (and if deceased, the date of death) was determined for all subjects in this analysis. All remaining subjects assumed at this point to still be alive were cross-checked with the responders to more recent surveys from 2002 to 2004. Th rough this, a small subset of subjects were identifi ed that had not responded and had a last contact date in the database of more than 2 years before the onset of this study. A list of this group of subjects was sent to the Mayo Survey Research Center, which used the Accurint database to track down addresses, phone numbers, and vital status ( 37 ) . Th ese methods were used to identify which of the survey respondents had died over the 15-year follow-up period (through April 2008). For deceased subjects, cause of death was obtained through use of Minnesota Death Tapes. For deceased subjects not found on the
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Minnesota Death Tapes, the Accurint system was used to request death certifi cates; causes of death were then obtained through review of these certifi cates. On the basis of previous cohort studies from Olmsted County, the methods applied have been demonstrated to be exhaustive with near complete ascertainment of deaths ( 38 -40 ) .
Charlson Comorbidity Index and other risk factors
Developed in 1987 from a cohort of 559 medical patients, the Charlson Comorbidity Index (CCI) encompasses 19 weighted categories of comorbidity, including myocardial infarction, congestive heart failure, chronic pulmonary disease, peripheral vascular disease, cerebrovascular disease, hemiplegia, liver disease (including mild vs. moderate or severe), diabetes mellitus, diabetes with end organ damage, AIDS, tumor, metastatic tumor, leukemia, lymphoma, ulcer disease, renal disease, dementia, and connective tissue disease ( 41 ) . Th e CCI has demonstrated good predictive validity and reliability for a variety of clinical outcomes similar to that of other comorbidity indices ( 42 ). Deyo et al. further developed the CCI for use with the International Classifi cation of Diseases, 9th Revision, Clinical Modifi cation (ICD-9-CM) administrative databases and codes ( 43 ) . Th e Rochester Epidemiology Project adapted the CCI for use based on the electronic medical index using ICD-9-CM codes. As the overall distribution in the total sample indicated that few subjects had more than two of the diseases included in the CCI, the proportional hazards regression analysis incorporated the morbidity index categorized as none vs. one or more.
Notable risk factors collected at baseline included alcohol use, smoking, and socioeconomic status. Alcohol use was categorized as none vs. one to six standard drinks per week vs. seven or more drinks per week. Smoking was recorded as yes / no regarding current status. Socioeconomic status was measured by education level and this was categorized as college graduate / professional training vs. high school / some college vs. less than high school.
Statistical analysis
Th e association between survival and each of the FGID (dyspepsia, functional constipation, IBS, abdominal pain, and functional diarrhea) was assessed using proportional hazards regression models to compute hazard ratios (HRs) with 95 % confi dence intervals (CIs). To account for potential confounding factors, HRs were also estimated adjusting for age at time of survey, gender, education level, CCI, alcohol use, and smoking. Kaplan -Meier estimates of overall survival, separately for each FGID analysis subset, were plotted and an overall observed vs. expected survival for the whole cohort was constructed. Expected survival was based on the age-and gender-specifi c features of the whole cohort using the survival characteristics of the Minnesota Caucasian population.
Th e association between survival and burden of FGIDs (e.g., number of FGIDs) was also assessed using proportional hazards regression models to compute HRs with 95 % CIs. Multiple variable analyses, adjusting for the same factors used for each FGIDs and survival, were also examined.
Study power
On the basis of the distribution of subjects for a specifi c FGID (e.g., 10 % with IBS vs. 90 % without), the univariate hazards ratios that could be detected with ~ 80 % power (two-sided α = 0.05) assuming 1,100 events ( " deaths " ) were estimated.
Irritable bowel syndrome . With 397 subjects reporting symptoms of IBS, there was 80 % power to detect an HR of 1.33, or greater (corresponding to a 33 % increase in risk relative to those without symptoms of IBS).
Functional. constipation . With 622 subjects reporting symptoms of functional constipation, there was 80 % power to detect an HR of 1.27.
Functional diarrhea . With 694 subjects reporting symptoms of functional diarrhea, there was 80 % power to detect an HR of 1.26.
Dyspepsia . With. 68 subjects reporting symptoms of dyspepsia, there was 80 % power to detect an HR of 1.91.
Abdominal pain . With 596 subjects reporting symptoms of frequent abdominal pain, there was 80 % power to detect an HR of 1.28.
Th us, this study had adequate power to detect a clinically relevant survival disadvantage for each of the disorders. If an adjustment for multiple FGIDs analyzed is used, a Bonferroni-adjusted α level of 0.01 (i.e., 0.05 divided by 5 FGIDs) would provide an overall Type 1 error rate of at most 5 % .
RESULTS
Demographics
A total of 4,176 subjects responded to the surveys (overall response rate of 79 % ), and the response rates for each survey were over 70 % . From these respondents, 243 subjects were excluded because of lack of research authorization (or were registered solely at a diff erent medical institution in Olmsted County, MN), resulting in 3,933 eligible subjects for analysis (eligible response rate 75 % ). Th e mean (s.d.) age of the respondents at baseline was 54 (18) years and 52 % were women.
Overall, 10 % of the population reported symptoms of IBS, 16 % reported constipation, 18 % diarrhea, 2 % dyspepsia, and 15 % abdominal pain. Th e sociodemographic factors and CCI are summarized in Table 1 .
Survival
Th ere were 1,101 deaths observed in the cohort through the last follow-up point of April 2008. Table 2 provides the results from the univariate proportional hazards regression models, which indicated poorer survival with increasing baseline age, male gender, smokers, and worsening CCI scores. Overall observed vs expected survival for the whole set of respondents is illustrated in Figure 1 , which suggested slightly better survival in respondents ( P = 0.09, log rank test).
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with and without constipation, respectively ( P < 0.001, log rank test for overall survival in this restricted subset). In addition, the association of constipation with overall survival was examined based on the severity of constipation. Severity was categorized using the number of constipation symptoms endorsed by each subject (e.g., none, one out of four, two out of four, three or greater out of four). Using no reported symptoms as the reference category, a consistent " dose response " association was not observed, although those with two symptoms did have an increased HR (HR = 1.3 (95 % CI: 1.1, 1.6), P < 0.005) relative to no symptoms reported, whereas those reporting three or four symptoms did not, adjusted for age, gender, and CCI. Table 2 ). Th is association was not appreciably altered when adjusted for smoking, education, alcohol use, and CCI ( Table 3 ).
Functional constipation . At 10 years, the estimated survival was 73 % among those reporting constipation (95 % CI: 69, 76) vs. 85 % in subjects not reporting constipation (95 % CI : 84, 86) ( Figure 2b ). Aft er adjusting for age and gender, constipation was associated with worse survival (HR = 1.23 (95 % CI: 1.07 -1.42), P = 0.005, Table 2 ). Th is association remained signifi cant ( P = 0.01) when adjusted for smoking, education, alcohol use, and CCI ( Table 3 ). Restricting the analysis to subjects without any of the comorbidities in the CCI, the 10-year survival rates were 85 % (95 % CI: 82, 88) and 93 % (95 % CI: 92, 94) for those 
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CI: 0.90 -1.19), Table 2 ). Th is association was not appreciably altered when adjusted for smoking, education, alcohol use, and CCI ( Table 3 ).
Dyspepsia . At 10 years, the estimated survival was 93 % among those reporting dyspepsia (95 % CI: 87, 99) vs. 83 % in subjects not reporting dyspepsia (95 % CI 82, 84) ( Figure 2d ). Aft er adjusting for age and gender, dyspepsia was not associated with survival (HR = 1.08 (95 % CI: 0.58 -2.02), Table 2 ). Th is association was not appreciably altered when adjusted for smoking, education, alcohol use, and CCI ( Table 3 ) . Table 2 ). Th is association was not appreciably altered when adjusted for smoking, education, alcohol use, and CCI ( Table 3 ) .
Causes of death
Th e causes of death for each FGID are given in Table 4 . No association between specifi c cause of death and each specifi c FGID was detected. Th e number of GI cancers occurring within each FGID group during the follow-up period is presented in Table 5 ; no signifi cant associations were detected.
Burden of FGIDs and survival
Th e association between burden of FGIDs and survival was evaluated and decreased survival was signifi cant in the univariate analysis for those with two (HR = 1.23 (95 % CI 1.04, 1.44)) and four (HR = 3.18 (95 % CI 1.02, 9.98)) FGID. However, these associations for two (HR = 
DISCUSSION
FGIDs are common in the community and despite signifi cant impact on health-care usage and resultant economic burden have been traditionally perceived as relatively benign disorders without adverse prognoses. However, this assumption is made despite a paucity of data from large-scale population-based studies evaluating whether FGIDs have an actual impact on survival. Communitybased investigations of FGIDs is crucial given that the majority of patients with FGIDs do not seek care for their symptoms ( 4,5 ). In CI, confi dence interval; GI, gastrointestinal; IBS, irritable bowel syndrome. a Univariate hazard ratios adjusted for gender and age.
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that may potentially resolve their symptoms ( 49 ) . Despite these considerations, we did not fi nd any association with IBS and poorer survival. Of note, better survival was not observed either, despite the increased usage of health-care resources seen in this group. Whether this lack of either association refl ects a balance between excess risk exposure and benefi ts of frequent health-care visits is uncertain. Nonetheless, the fi ndings of this study for IBS are reassuring. Dyspepsia and abdominal pain are two upper GI symptoms that are commonly seen in the general population. Similar to IBS, subjects with symptoms of dyspepsia or abdominal pain have greater health seeking behavior over the general population ( 50 ) . Unlike abdominal pain, dyspepsia has been reported earlier to be associated with poorer survival in a study from the United Kingdom ( 51 ) . However, the study had various limitations that include subjects with dyspepsia who were obtained from the general practice setting were identifi ed solely based on diagnosis codes from the Oxford Medical Information System and subjects with dyspepsia were more likely to be diagnosed with angina or chest pain, which raises the question of excess mortality from overlooked cardiac causes. In contrast to the UK fi ndings, the this population-based cohort study with over 30,000 person-years of follow-up, no signifi cant association was observed between survival and IBS, chronic diarrhea, dyspepsia, or abdominal pain. Furthermore, no association was found between an increasing burden of FGIDs and survival. However, in contrast to these other FGIDs, subjects with symptoms of chronic constipation were found to be at increased risk of poorer survival.
IBS is one of the most common FGIDs in the community with a prevalence in North America reported as high as 20 % , with most estimates ranging between 10 to 20 % ( 44 ). Th is translates into ~ 30 million people with symptoms meeting the criteria for IBS. Th e economic burden posed by IBS is considerable and appears to not only arise from its high prevalence in the community, but also from a disproportionately high consumption of health-care resources ( 45 -47 ) . Th is disparate usage of resources oft en involves various invasive procedures as well as surgeries such as cholecystectomy, appendectomy, and hysterectomy ( 45, 48 ) . Th e willingness of patients with IBS to undergo the risks of invasive testing and surgeries is not surprising, given other data suggesting that these patients are willing to expose themselves to considerable risk, and even death, for a therapy 
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subjects with dyspepsia from our study were identifi ed by symptom-based criteria in a population-based setting; comorbidities, including myocardial infarction and congestive heart failure, were adjusted for in the multiple variable analyses with the CCI.
Th erefore, our results showing no association between dyspepsia and survival may more accurately refl ect the community perspective than has been reported earlier. Although the percent of our population reporting symptoms of dyspepsia was unexpectedly 
factors and not the constipation itself. However, it may be diffi cult to apply this argument to our results given that (i) individuals with any signifi cant illnesses were excluded at baseline from the mailings, (ii) the association found remained signifi cant despite adjusting for comorbidities through the CCI, and (iii) the 10-year survival rates were still signifi cantly lower in those with constipation even when comparing subjects without any of the comorbidities. Despite our careful analyses, caution is recommended regarding this fi nding given the lack of association found between survival and the other FGIDs included in this study. An increased mortality in constipation not only contradicts the majority of fi ndings of this study, but also we could not account for the excess mortality despite examining causes of death and frequency of GI malignancies. Further investigation is clearly needed to explore whether these fi ndings are spurious or indeed meaningful.
One limitation of our study is that the racial majority (at ~ 90 % ) of our Olmsted County study population was Caucasian. Th us, these data may be only applicable to the Caucasian population and not other ethnic groups. Response bias is possible, but this seems less likely given the reasonable response rate and lack of diff erences between responders and nonresponders that is now well documented in this population ( 57 ) . Although an earlier validated symptom questionnaire was applied, it is possible that measurement bias infl uenced the results. Recall bias may have been increased because symptoms were assessed over the previous year, although in validation testing locally this has not been an issue ( 31 ) . Th e power calculations performed were also post hoc . Referral bias is a remote consideration given that although subjects were recruited randomly from a population-based setting, subjects were limited to those who had received care at some time from the Mayo Clinic, given the use of the earlier discussed institutional database (or " Registration " ) as part of the methods for determination of vital status. Th e transition between FGIDs over time may result in misclassifi cation bias ( 1 ) . However, as misclassifi cation bias oft en results in an underestimation of a low at 2 % , this may refl ect (1) our exclusion of subjects with IBS and the overlap that is commonly seen between these two groups and (2) a more stringent defi nition used here in terms of requirements for how frequent symptoms occurred (e.g., nausea and vomiting both required episodes occurring at least three or more times per week). Given the population-based setting of our study and more stringent defi nition used, our fi ndings for dyspepsia are felt to be both reassuring and more refl ective of patients with dyspepsia in the community.
Subjects with lower GI symptoms oft en complain of a spectrum of symptoms that oft en include both diarrhea and constipation. Chronic diarrhea can be a manifestation of various disorders including infl ammatory bowel disease, malabsorption syndromes, and chronic infections. In contrast, functional diarrhea occurs in the absence of obvious biochemical or structural etiologies. In this study, we found no association between functional diarrhea and survival. We made multiple eff orts to ensure that other causes of chronic diarrhea were excluded from the diarrhea group; subjects with IBS were also excluded.
However, despite the lack of association found between survival and the multiple FGIDs described above, we found that subjects with symptoms of chronic constipation had poorer survival. Th is fi nding was signifi cant in both the univariate and multiple variable analyses, which adjusted for smoking, education level, alcohol use, and the CCI. Explaining this fi nding is diffi cult, especially in light of the lack of associations found for the other FGIDs. Given the data from multiple studies suggesting that constipation is associated with an increase risk for colorectal adenocarcinoma ( 52 -56 ), we explored whether the observed excess mortality may be secondary to deaths from colorectal cancer. Although not a primary endpoint of this study, we found no association between symptoms of constipation and colorectal cancer or any other GI malignancy. Another possible explanation for our fi nding is that symptoms of constipation may be a surrogate for general health status and refl ective of underlying comorbidities, and poorer survival is actually secondary to these Anal / rectal / colon, n ( 
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true association, our fi ndings for constipation despite this bias is notable. In summary, FGIDs are common in the community and pose a signifi cant health-care burden. Although commonly assumed to be benign, there has been a lack of large-scale population-based studies examining whether or not FGIDs are associated with increased mortality. Th e results from this population-based cohort study are largely reassuring in that no association was found between survival and symptoms of IBS, functional diarrhea, dyspepsia, or abdominal pain. In light of these fi ndings, caution should be applied regarding our observation that chronic constipation is associated with poorer survival. Whether this fi nding is spurious or secondary to an underlying process requires further investigation.
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